×
×
×
×
×

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
  
data?.title

Navigating a Reopening in Health Care

June 1, 2022

ClearBridge Investments · Can the Fed Engineer a Soft Landing?

Health Care Analyst Marshall Gordon and Portfolio Manager Jean Yu join Jeff Schulze to discuss the macro headwinds facing the health care sector and why they are favoring larger cap companies in a volatile equity market.

Related Perspectives

Tailwinds Forming for Health Care
Podcast: Improved biopharma funding is proving beneficial to CROs and life science tools companies while patent expirations are separating pharmaceuticals.
Value’s Lead Holds Through Growth Rebound
Value 2Q26: Growth and AI infrastructure led the second-quarter rebound, but value remained ahead year to date on cash flow durability and real asset exposure.
Gaining Flexibility in Shifting Growth Market
Large Cap Growth 2Q26: We believe benchmark changes, greater portfolio latitude and continued AI infrastructure leadership create a strong setup for the second half.
Narrow Market Full of Overlooked Value
Dividend Strategy 2Q26: With record market concentration despite uncertainty introduced by profound technological change, diversification is paramount.
Keeping Discipline in a Momentum Market
Small Cap 2Q26: Small caps rebounded sharply in the second quarter, but concentrated AI- and momentum-led leadership challenged a diversified, risk-aware approach.
More
  • Copyright © 2022 ClearBridge investments. 

  • All opinions and data included in this commentary are as of the publication date and are subject to change. The opinions and views expressed herein are of the author and may differ from other portfolio managers or the firm as a whole, and are not intended to be a forecast of future events, a guarantee of future results or investment advice. This information should not be used as the sole basis to make any investment decision. The statistics have been obtained from sources believed to be reliable, but the accuracy and completeness of this information cannot be guaranteed. Neither ClearBridge Investments, LLC  nor its information providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

  • Performance source: Internal. Benchmark source: Standard & Poor's.

  • Source: London Stock Exchange Group plc and its group undertakings (collectively, the “LSE Group”). © LSE Group 2026. FTSE Russell is a trading name of certain of the LSE Group companies. “Russell®” is a trade mark of the relevant LSE Group companies and is/are used by any other LSE Group company under license. All rights in the FTSE Russell indexes or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indexes or data and no party may rely on any indexes or data contained in this communication. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company’s express written consent. The LSE Group does not promote, sponsor or endorse the content of this communication.

more